Market-entry checklist · free tool

Entering the South African healthcare market: the readiness a launch plan often misses

Market entry stalls when the operating structure, regulatory authorisation, route to market and pricing route are decided out of sequence. Work through the 16 questions below before you commit to a launch date.

0 of 16 reviewed

01 · Operating structure & entity

Which South African entity will hold the business — a subsidiary, a branch or a local partner or distributor — and does the choice fit the regulatory role it must play?Does the chosen entity have the standing to hold the licences, marketing authorisations and contracts the market activity requires?

02 · Regulatory authorisation

What SAHPRA registrations and establishment licences are needed for the products or activities, and who will hold them — you or a local party?Is the regulatory timeline mapped against the commercial launch date, with the critical-path approvals sequenced?For devices, diagnostics or complementary medicines: is the applicable regime and its transitional requirements understood?

03 · Route to market & contracts

Will you appoint a distributor, agent or wholesaler, or contract directly — and are territory, exclusivity, forecasting, pricing and termination settled?Is responsibility for import, warehousing, cold chain and recall allocated clearly?Are the marketing-authorisation holder and the party carrying regulatory responsibility documented, not assumed?

04 · Pricing, reimbursement & procurement

Do the commercial terms account for the local pricing regime (the single exit price where it applies) and any tender or procurement route?Are supply commitments and forecasts realistic against the registration and import timeline?

05 · Data, IP & compliance

Is POPIA addressed for any personal data processed (patients, healthcare professionals, employees), including cross-border transfer?Is the IP position — trade marks, patents, licences — secured in South Africa before launch?Are anti-bribery, healthcare-professional-interaction and marketing-code requirements built into the local operating model?

06 · People, tax & exchange control

Are the employment, immigration and B-BBEE implications of the local structure understood?Are the tax and exchange-control consequences of the funding and profit-repatriation model scoped?

07 · Sequencing

Is there a single owner of the critical path — entity, then licences, then contracts, then launch — so the legal and regulatory steps are sequenced against the commercial deadline?

General orientation only — not legal advice, and no attorney-client relationship arises from its use. A specific matter requires a written engagement.